AcuFocus receives $66 million in funding from KKR

COPENHAGEN — AcuFocus received a private investment of approximately $66 million from global investment firm KKR, the company announced in a press release.AcuFocus will use the financing to accelerate its commercialization plans for the Kamra corneal inlay and IC-8 IOL, in addition to research and development projects, according to the release.

Increasing evidence proves value, reliability and benefits of OCT angiography

COPENHAGEN — OCT angiography is establishing itself as a reliable, easy to perform, noninvasive tool for the evaluation of disease progression and treatment-related improvement in retinal diseases such as age-related macular degeneration, diabetic retinopathy and retinal vein occlusion. “Two studies, one published by our group and one by the group of David Sarraf, have recently demonstrated that the information and results provided by OCTA and fluorescein angiography are virtually the same. This is a very important achievement because we have proved that we can trust the method,” Gabriel Coscas, MD, (Read more...)

Study: Chronic inflammation of familial Mediterranean fever affects choroidal thickness

COPENHAGEN — Chronic inflammation might have an effect on thinning of the choroid, according to a speaker here.In a study of 50 patients with familial Mediterranean fever gene mutation and 50 control subjects, Tolga Biçer, MD, and colleagues found statistically significant differences in choroidal thickness between the two groups in central and nasal measurements.